decisionhealth Newsletters, Coder Pink Sheets - 2012 Issue 1 (January)
Inside CCI: Manual clarifies debridement, bilateral injection coding
Subscribe or sign in to view the full article.
Article Overview
This article reviews selected changes from a Medicare CCI manual update and explains the general areas affected, including bilateral services, debridement, cardiovascular procedures, imaging, laboratory testing, medicine, ophthalmology, therapy, and HCPCS drug coding. It is intended for coders, billers, auditors, and compliance staff who need to understand which topics were updated and where related guidance appears in the CCI framework.
Why This Topic Matters
The update affects how common services are reported across several clinical settings and code sets, so coders and compliance teams need to know which chapters and service categories were revised.
Article Sections
-
Chapter 1 – General Coding Guidelines
Overview of general CCI policy updates affecting bilateral services and site-based reporting considerations.
-
Chapter 3 - Integumentary
Discussion of updated CCI guidance affecting skin, wound, graft, and debridement-related services.
-
Cardiovascular
Coverage of vascular and interventional cardiovascular coding topics, including repair, angiography, thrombolysis, embolization, and imaging-related guidance.
-
Chapter 8 - Nervous
Summary of guidance related to spinal procedures and add-on code reporting in the nervous system chapter.
-
Chapter 9 – Radiology
Overview of radiology-related CCI guidance for diagnostic nuclear studies and nuclear therapy.
-
Chapter 10 – Path/Laboratory
Highlights of laboratory policy changes involving urine drug testing and related billing limits.
-
Chapter 11 – Medicine
Medicine chapter updates addressing substance abuse assessment, E/M coding, ophthalmology-related visual field testing, cardiac rehabilitation, pulmonary angiography, and therapy services.
-
Chapter 12 – HCPCS codes
HCPCS-level guidance on drug coding, MUE-related considerations, and selected injectable and compounded drug reporting topics.
What You Will Learn
- Which CCI chapters were updated in the annual manual revision
- What broad service categories were affected by the update
- How the article frames bilateral, debridement, imaging, laboratory, and drug-coding topics
- Which specialties and code sets are discussed in the report
Who Should Read This
- Medical coders
- Billing staff
- Compliance auditors
- Revenue cycle professionals
- Physician practice administrators
Codes Discussed
Code Ranges Discussed
Modifiers Discussed
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com